Skip to content

Septerna, Inc. SEPN Enterprise value

Enterprise value at other companies

Amgen logo
AmgenAMGN
$246.43B+9.9%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$1.77B+1,855%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$1.43B+352%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$1.63B+45.1%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$1.85B-0.8%
Precigen logo
PrecigenPGEN
$1.46B+234%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.65B+319%
P/S22.8×-379×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s enterprise value?
Septerna, Inc. (SEPN) reported enterprise value of $1.03B in Q1 2026.
How has Septerna, Inc.'s enterprise value changed year-over-year?
Septerna, Inc.'s enterprise value increased by 1325.4% year-over-year, from $72.3M to $1.03B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.